in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Roche Opens R&D Unit to Develop Formulations for New APIs
5:56 AM MST | November 28, 2011 | Deepti Ramesh
Roche (Basel, Switzerland) says it has opened a new R&D center for innovative formulation processes and technologies at Basel, which involved an investment of SF250 million ($271 million). The facility will investigate and develop pharmaceutical formulations for new active pharmaceutical ingredients (APIs), as well as manufacture supplies for global clinical trials. “Finding the safest and most efficient formulation for an active ingredient is a key part of the drug development process,” says Severin Schwan, CEO of Roche. “Functions from the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee